Search - tctmd.com

Displaying 241 - 260 of 457

Sort: Relevancy | Date

News Conference News ACC 2021

ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19

Todd Neale

May 17, 2021

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Shelley Wood

May 16, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Conference News ACC 2021

Prediabetes Linked to Higher MACE Risk

Todd Neale

May 10, 2021

News Conference News SCAI 2021

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Michael O'Riordan

April 28, 2021

News Daily News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Michael O'Riordan

March 03, 2021

News Daily News

Prophylactic Anticoagulation, Fewer Deaths in Hospitalized COVID-19 Patients

Michael O'Riordan

February 15, 2021

News Daily News

FDA Approves Evinacumab for Rare Homozygous FH

Michael O'Riordan

February 11, 2021

News Daily News

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Michael O'Riordan

February 04, 2021

News Daily News

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

Todd Neale

February 01, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

New Advanced Training Outlined for Future Vascular Medicine Specialists

Michael O'Riordan

January 21, 2021

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

Michael O'Riordan

January 20, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

News Conference News AHA 2020

Rilonacept Prevents Recurrent Pericarditis: RHAPSODY

Shelley Wood

November 17, 2020

News Conference News AHA 2020

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Michael O'Riordan

November 12, 2020

News Opinion CV Team Dispatch

November 2020 News Roundup

L.A. McKeown

November 01, 2020

Advertisement

ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Prediabetes Linked to Higher MACE Risk

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Prophylactic Anticoagulation, Fewer Deaths in Hospitalized COVID-19 Patients

FDA Approves Evinacumab for Rare Homozygous FH

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

February 2021 News Roundup

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

New Advanced Training Outlined for Future Vascular Medicine Specialists

FDA Approves Vericiguat for High-risk Patients With HF

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Inclisiran Approved in Europe for Lowering LDL Cholesterol

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Rilonacept Prevents Recurrent Pericarditis: RHAPSODY

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

November 2020 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content